OTCMKTS:SHWZ

Medicine Man Technologies (SHWZ) Stock Price, News & Analysis

$0.63
-0.03 (-4.57%)
(As of 04/26/2024 ET)
Today's Range
$0.61
$0.67
50-Day Range
$0.63
$1.45
52-Week Range
$0.48
$1.55
Volume
42,381 shs
Average Volume
64,128 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.50
SHWZ stock logo

About Medicine Man Technologies Stock (OTCMKTS:SHWZ)

Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. It operates through Retail, Wholesale, and Others segments. The company offers loose flower, concentrates, edibles, pre-rolls, topicals, infused beverages, and other associated cannabis products produced by cannabis vendors; and cannabis and non-cannabis products. It operates retail cannabis dispensaries under the Star Buds, Emerald Fields, Standing Akimbo, Everest Cannabis Co., and R. Greenleaf brand names. In addition, the company sells indoor gardening supplies and hydroponics through its online and retail store. Medicine Man Technologies, Inc. was incorporated in 2014 and is headquartered in Denver, Colorado.

SHWZ Stock Price History

SHWZ Stock News Headlines

It’s now possible to know the win rate of every trade… BEFORE you take it!
Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.
It’s now possible to know the win rate of every trade… BEFORE you take it!
Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.
First Day of Medieval Medicine 101
See More Headlines
Receive SHWZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicine Man Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/28/2024
Next Earnings (Estimated)
5/08/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:SHWZ
Fax
N/A
Employees
729
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.50
High Stock Price Target
$2.50
Low Stock Price Target
$2.50
Potential Upside/Downside
+299.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Daniel R. Pabon (Age 46)
    Chief Policy & Regulatory Affairs Officer
    Comp: $283.96k
  • Mr. Forrest Hoffmaster
    Chief Financial Officer
  • Ms. Christine Jones
    Chief Legal Officer
  • Mr. Dan Bonach
    Vice President of Human Resources
  • Mr. Todd Williams
    Executive Vice President of M&A and Real Estate
  • Dr. Jim Parco
    President of Schwazze Biosciences Ltd.
  • Mr. Christopher Lee Driessen
    Executive Vice President of Commercial Sales
  • Mr. Collin Lodge
    President of Colorado Division
  • Mr. David Kaufman
    Executive Vice President of Integrated Supply Chain
  • Ed Eissenstat
    VP of Information Technology & C.I.O

SHWZ Stock Analysis - Frequently Asked Questions

Should I buy or sell Medicine Man Technologies stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medicine Man Technologies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" SHWZ shares.
View SHWZ analyst ratings
or view top-rated stocks.

What is Medicine Man Technologies' stock price target for 2024?

1 brokers have issued twelve-month price targets for Medicine Man Technologies' shares. Their SHWZ share price targets range from $2.50 to $2.50. On average, they anticipate the company's stock price to reach $2.50 in the next twelve months. This suggests a possible upside of 299.4% from the stock's current price.
View analysts price targets for SHWZ
or view top-rated stocks among Wall Street analysts.

How have SHWZ shares performed in 2024?

Medicine Man Technologies' stock was trading at $0.6097 at the beginning of 2024. Since then, SHWZ shares have increased by 2.7% and is now trading at $0.6260.
View the best growth stocks for 2024 here
.

Are investors shorting Medicine Man Technologies?

Medicine Man Technologies saw a drop in short interest in April. As of April 15th, there was short interest totaling 1,000 shares, a drop of 44.4% from the March 31st total of 1,800 shares. Based on an average daily trading volume, of 103,200 shares, the days-to-cover ratio is presently 0.0 days.
View Medicine Man Technologies' Short Interest
.

When is Medicine Man Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our SHWZ earnings forecast
.

What other stocks do shareholders of Medicine Man Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medicine Man Technologies investors own include Charlotte's Web (CWBHF), GrowGeneration (GRWG), Harvest Health & Recreation (HRVSF), Trulieve Cannabis (TCNNF), Curaleaf (CURLF), Amplify Alternative Harvest ETF (MJ), Organigram (OGI), Village Farms International (VFF) and Cresco Labs (CRLBF).

How do I buy shares of Medicine Man Technologies?

Shares of SHWZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:SHWZ) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners